ProShare Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,182
| Closed | -$907K | – | 2449 |
|
|
2021
Q1 | $907K | Sell |
4,182
-456
| -10% | -$85.7K | ﹤0.01% | 1051 |
|
|
2020
Q4 | $535K | Sell |
4,638
-186
| -4% | -$20.8K | ﹤0.01% | 1232 |
|
|
2020
Q3 | $470K | Buy |
4,824
+66
| +1% | +$7.59K | ﹤0.01% | 976 |
|
|
2020
Q2 | $584K | Buy |
4,758
+694
| +17% | +$78.7K | ﹤0.01% | 882 |
|
|
2020
Q1 | $356K | Sell |
4,064
-2,310
| -36% | -$245K | ﹤0.01% | 825 |
|
|
2019
Q4 | $666K | Sell |
6,374
-1,592
| -20% | -$179K | ﹤0.01% | 946 |
|
|
2019
Q3 | $916K | Sell |
7,966
-570
| -7% | -$86.5K | 0.01% | 770 |
|
|
2019
Q2 | $1.47M | Sell |
8,536
-1,318
| -13% | -$228K | 0.01% | 653 |
|
|
2019
Q1 | $1.66M | Buy |
9,854
+764
| +8% | +$114K | 0.01% | 644 |
|
|
2018
Q4 | $885K | Sell |
9,090
-1,757
| -16% | -$231K | 0.01% | 739 |
|
|
2018
Q3 | $1.87M | Sell |
10,847
-295
| -3% | -$42.5K | 0.01% | 628 |
|
|
2018
Q2 | $1.55M | Sell |
11,142
-1,097
| -9% | -$156K | 0.01% | 679 |
|
|
2018
Q1 | $1.38M | Sell |
12,239
-491
| -4% | -$61.7K | 0.01% | 714 |
|
|
2017
Q4 | $1.68M | Sell |
12,730
-495
| -4% | -$58.2K | 0.01% | 660 |
|
|
2017
Q3 | $1.34M | Buy |
13,225
+1,203
| +10% | +$129K | 0.01% | 661 |
|
|
2017
Q2 | $1.21M | Sell |
12,022
-241
| -2% | -$25.9K | 0.01% | 677 |
|
|
2017
Q1 | $1.48M | Sell |
12,263
-188
| -2% | -$23.1K | 0.02% | 637 |
|
|
2016
Q4 | $1.39M | Buy |
12,451
+2,421
| +24% | +$291K | 0.02% | 652 |
|
|
2016
Q3 | $1.33M | Sell |
10,030
-1,466
| -13% | -$140K | 0.02% | 605 |
|
|
2016
Q2 | $1.05M | Buy |
11,496
+176
| +2% | +$14.8K | 0.01% | 701 |
|
|
2016
Q1 | $817K | Sell |
11,320
-855
| -7% | -$46.9K | 0.01% | 782 |
|
|
2015
Q4 | $845K | Buy |
12,175
+734
| +6% | +$59.8K | 0.01% | 816 |
|
|
2015
Q3 | $1.04M | Buy |
11,441
+1,913
| +20% | +$213K | 0.01% | 661 |
|
|
2015
Q2 | $1.17M | Buy |
9,528
+31
| +0.3% | +$3.52K | 0.02% | 705 |
|
|
2015
Q1 | $865K | Buy |
9,497
+1,616
| +21% | +$131K | 0.01% | 920 |
|
|
2014
Q4 | $533K | Buy |
+7,881
| New | +$576K | 0.01% | 1164 |
|
Other funds holding GWPH
ProShare Advisors's GWPH Position: Q2 2021 in Review
ProShare Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 4,182 shares — an estimated $907K sold.
ProShare Advisors first reported a position in GWPH in Q4 2014 and held it in 26 quarters. The position peaked at $1.87M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- ProShare Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- ProShare Advisors sold 4,182 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $907K.
- ProShare Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 26 quarters.
- ProShare Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.87M in Q3 2018.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.